Reported Saturday, Prothena Partners Roche And Bristol Myers Squibb Present Clinical Data Supporting Next-Generation Prasinezumab And BMS-986446 Treatments For Parkinson's And Alzheimer's Disease At AD/PD 2026

Benzinga Newsdesk www.benzinga.com Positive 66.1%

Neg 0% Neu 0% Pos 66.1%

Comments

No comments yet. Be the first!